These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3197744)

  • 1. Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man.
    Keech AC; Harper RW; Harrison PM; Pitt A; McLean AJ
    Eur J Clin Pharmacol; 1988; 35(4):363-6. PubMed ID: 3197744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance-based oral drug interaction between verapamil and metoprolol and comparison with atenolol.
    McLean AJ; Knight R; Harrison PM; Harper RW
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1628-9. PubMed ID: 4003307
    [No Abstract]   [Full Text] [Related]  

  • 3. Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.
    van Baak MA; Mooij JM; Schiffers PM
    Eur J Clin Pharmacol; 1992; 43(5):547-50. PubMed ID: 1483493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.
    Vogelpoel H; Welink J; Amidon GL; Junginger HE; Midha KK; Möller H; Olling M; Shah VP; Barends DM
    J Pharm Sci; 2004 Aug; 93(8):1945-56. PubMed ID: 15236445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
    Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.
    McCourty JC; Silas JH; Tucker GT; Lennard MS
    Br J Clin Pharmacol; 1988 Mar; 25(3):349-57. PubMed ID: 3358897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit.
    De Cicco M; Macor F; Robieux I; Zanette G; Fantin D; Fabiani F; Nicolosi G; Fracasso A; Toffoli G; Santantonio C; Lestuzzi C; Matovic M; Boiocchi M
    Crit Care Med; 1999 Feb; 27(2):332-9. PubMed ID: 10075058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of dilevalol (i.v.). Influence of hepatic and renal functions on the disposition of dilevalol and atenolol in hypertensive subjects.
    Kotegawa T; Fujimura A; Ebihara A
    J Clin Pharmacol; 1990 May; 30(5):404-8. PubMed ID: 2347954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: effects on cardiac function and drug clearance.
    Holtzman JL; Finley D; Mottonen L; Berry DA; Ekholm BP; Kvam DC; McQuinn RL; Miller AM
    Clin Pharmacol Ther; 1989 Jul; 46(1):26-32. PubMed ID: 2501057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection.
    Greenblatt DJ; Patel M; Harmatz JS; Nicholson WT; Rubino CM; Chow CR
    J Clin Pharmacol; 2018 Apr; 58(4):533-540. PubMed ID: 29194698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral bioavailability of atenolol.
    Vergin H; Nitsche V
    J Int Med Res; 1989; 17(5):417-25. PubMed ID: 2806714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of steady-state verapamil plasma concentrations in children and adults.
    Wagner JG; Rocchini AP; Vasiliades J
    Clin Pharmacol Ther; 1982 Aug; 32(2):172-81. PubMed ID: 7094504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective pharmacokinetics of atenolol in the rat: influence of aging and of renal failure.
    Belpaire FM; Rosseel MT; Vermeulen AM; De Smet F; Bogaert MG
    Mech Ageing Dev; 1993 Feb; 67(1-2):201-10. PubMed ID: 8469031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Gorski JC; Wainer IW; Schwartz JB
    Clin Pharmacol Ther; 1999 Jul; 66(1):40-50. PubMed ID: 10430108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlates.
    Barbarash RA; Bauman JL; Fischer JH; Kondos GT; Batenhorst RL
    Chest; 1988 Nov; 94(5):954-9. PubMed ID: 3180898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of racemic verapamil in patients with impaired renal function.
    Zachariah PK; Moyer TP; Theobald HM; Frantz RP; Kurtz SB; McCarthy JT; Smith RL
    J Clin Pharmacol; 1991 Jan; 31(1):45-53. PubMed ID: 2045528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.